Let’s talk about Kinases. NantOmics is a cancer drug startup that features a library of kinase inhibitors that could home in on multiple mutations that drive cancers regardless of whether tumors reside in the body; their dominance in this space arose after the acquisition of Celgene. Immune system evasion is a hallmark of cancer, the […]

Receptor Tyrosine Kinases (RTK), Leukemias and Lymphomas — Bruce Changlong Xu